drugset / Trial / NCT02312089
GnRHa for Luteal Phase Support in GnRH Antagonist Protocol Cycles
RandomizedParallel-groupOpen-labelSupportive care
Summary
Evaluation of the effect of adding a single dose of gonadotropin releasing hormone agonist (GnRHa) as a luteal phase support on the outcomes of intracytoplasmic sperm injection (ICSI) following GnRH antagonist protocol
Timeline
- Start
- 2016-08-07
- Primary completion
- 2024-12-31
- Completion
- 2024-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Triptorelin | Other / unclassified | 0.2 mg | Subcutaneous |